Bosutinib Tablet, Film Coated
Product Images NDC 46708-311

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Bosutinib (NDC 46708-311). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

120 Tablets (Bosutinib 100 mg)

Bosutinib Tablets 100 mg film-coated oral tablets by Alembic Pharmaceuticals Limited. The label indicates a package containing 120 tablets, with storage instructions between 20°C to 25°C, and notes for oncology use only. The label includes dosage guidance reference, manufacturing details, and a barcode.*

FDA Label Image

30 Tablets (Bosutinib 500 mg)

Bosutinib Tablets 500 mg film-coated oral tablets packaging label showing 30 tablets per package. Label includes storage instructions, manufacturer Alembic Pharmaceuticals Limited, and warnings such as 'Do not crush or cut tablet' and 'For Oncology Use Only.' NDC code 46708-312-30 is visible along with a barcode.*

FDA Label Image

Bosutinib-structure.jpg (Bosutinib Structure)

Chemical structure of Bosutinib, a small molecule with multiple ring systems, including chlorinated aromatic groups, nitrogen-containing heterocycles, and methoxy substituents, consistent with its kinase inhibitor function.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.